Report Detail
Global Oxytocic Pharmaceuticals Market Insights, Forecast to 2025
- RnM2716924 |
- 31 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
The global Oxytocic Pharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oxytocic Pharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Oxytocic Pharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oxytocic Pharmaceuticals in these regions.
This research report categorizes the global Oxytocic Pharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Oxytocic Pharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
Market size by Product
Natural Oxytocin
Synthetic Oxytocin Derivative
Market size by End User
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oxytocic Pharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oxytocic Pharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oxytocic Pharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oxytocic Pharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Oxytocic Pharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oxytocic Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Oxytocic Pharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Natural Oxytocin
- 1.4.3 Synthetic Oxytocin Derivative
- 1.5 Market by End User
- 1.5.1 Global Oxytocic Pharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Abortion Induced Incomplete
- 1.5.3 Inevitable Abortion
- 1.5.4 Post-partum Haemorrhage
- 1.5.5 Labour Induction
- 1.5.6 Labour Arrest
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oxytocic Pharmaceuticals Market Size
- 2.1.1 Global Oxytocic Pharmaceuticals Revenue 2014-2025
- 2.1.2 Global Oxytocic Pharmaceuticals Sales 2014-2025
- 2.2 Oxytocic Pharmaceuticals Growth Rate by Regions
- 2.2.1 Global Oxytocic Pharmaceuticals Sales by Regions
- 2.2.2 Global Oxytocic Pharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Oxytocic Pharmaceuticals Sales by Manufacturers
- 3.1.1 Oxytocic Pharmaceuticals Sales by Manufacturers
- 3.1.2 Oxytocic Pharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global Oxytocic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 Oxytocic Pharmaceuticals Revenue by Manufacturers
- 3.2.1 Oxytocic Pharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 Oxytocic Pharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 Oxytocic Pharmaceuticals Price by Manufacturers
- 3.4 Oxytocic Pharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 Oxytocic Pharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oxytocic Pharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into Oxytocic Pharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Oxytocic Pharmaceuticals Sales by Product
- 4.2 Global Oxytocic Pharmaceuticals Revenue by Product
- 4.3 Oxytocic Pharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Oxytocic Pharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America Oxytocic Pharmaceuticals by Countries
- 6.1.1 North America Oxytocic Pharmaceuticals Sales by Countries
- 6.1.2 North America Oxytocic Pharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Oxytocic Pharmaceuticals by Product
- 6.3 North America Oxytocic Pharmaceuticals by End User
7 Europe
- 7.1 Europe Oxytocic Pharmaceuticals by Countries
- 7.1.1 Europe Oxytocic Pharmaceuticals Sales by Countries
- 7.1.2 Europe Oxytocic Pharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oxytocic Pharmaceuticals by Product
- 7.3 Europe Oxytocic Pharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific Oxytocic Pharmaceuticals by Countries
- 8.1.1 Asia Pacific Oxytocic Pharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific Oxytocic Pharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Oxytocic Pharmaceuticals by Product
- 8.3 Asia Pacific Oxytocic Pharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America Oxytocic Pharmaceuticals by Countries
- 9.1.1 Central & South America Oxytocic Pharmaceuticals Sales by Countries
- 9.1.2 Central & South America Oxytocic Pharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Oxytocic Pharmaceuticals by Product
- 9.3 Central & South America Oxytocic Pharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Oxytocic Pharmaceuticals by Countries
- 10.1.1 Middle East and Africa Oxytocic Pharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa Oxytocic Pharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Oxytocic Pharmaceuticals by Product
- 10.3 Middle East and Africa Oxytocic Pharmaceuticals by End User
11 Company Profiles
- 11.1 Fresenius Kaci
- 11.1.1 Fresenius Kaci Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Fresenius Kaci Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Fresenius Kaci Oxytocic Pharmaceuticals Products Offered
- 11.1.5 Fresenius Kaci Recent Development
- 11.2 Biofutura
- 11.2.1 Biofutura Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Biofutura Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Biofutura Oxytocic Pharmaceuticals Products Offered
- 11.2.5 Biofutura Recent Development
- 11.3 Baxter
- 11.3.1 Baxter Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Baxter Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Baxter Oxytocic Pharmaceuticals Products Offered
- 11.3.5 Baxter Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Oxytocic Pharmaceuticals Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Ferring
- 11.5.1 Ferring Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Ferring Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Ferring Oxytocic Pharmaceuticals Products Offered
- 11.5.5 Ferring Recent Development
- 11.6 Novartis
- 11.6.1 Novartis Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Novartis Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Novartis Oxytocic Pharmaceuticals Products Offered
- 11.6.5 Novartis Recent Development
- 11.7 Teva
- 11.7.1 Teva Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Teva Oxytocic Pharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Teva Oxytocic Pharmaceuticals Products Offered
- 11.7.5 Teva Recent Development
12 Future Forecast
- 12.1 Oxytocic Pharmaceuticals Market Forecast by Regions
- 12.1.1 Global Oxytocic Pharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 Oxytocic Pharmaceuticals Market Forecast by Product
- 12.2.1 Global Oxytocic Pharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global Oxytocic Pharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 Oxytocic Pharmaceuticals Market Forecast by End User
- 12.4 North America Oxytocic Pharmaceuticals Forecast
- 12.5 Europe Oxytocic Pharmaceuticals Forecast
- 12.6 Asia Pacific Oxytocic Pharmaceuticals Forecast
- 12.7 Central & South America Oxytocic Pharmaceuticals Forecast
- 12.8 Middle East and Africa Oxytocic Pharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oxytocic Pharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oxytocic Pharmaceuticals . Industry analysis & Market Report on Oxytocic Pharmaceuticals is a syndicated market report, published as Global Oxytocic Pharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oxytocic Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
